Orphan Drugs

Orphan drugs are medications developed specifically to treat rare medical conditions, known as orphan diseases. These diseases affect a small percentage of the population, often making it unprofitable for pharmaceutical companies to invest in their treatment. As a result, governments offer incentives, such as financial aid and extended market exclusivity, to encourage the development of these drugs. The goal is to ensure that patients with rare conditions have access to effective treatments, even when these conditions might not be economically viable for drug developers.